Merck KGaA Specifies Guidance Amid Soft Semiconductor Market.

Merck KGaA expects to achieve sales at the lower end of its annual guidance range due to a slow recovery in the semiconductor materials market. The company's life science division is showing signs of growth, but its electronics business is performing well despite market challenges. Merck is focusing on finding new growth drivers in the face of competition and recent drug failures. Overall, third-quarter earnings exceeded analyst expectations, with the company based in Darmstadt, Germany. [Extracted from the article]

Copyright of Bloomberg.com is the property of Bloomberg, L.P. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)